SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts

被引：174

作者：

Visconte, V. ^{[1
]}

Makishima, H. ^{[1
]}

Jankowska, A. ^{[1
]}

Szpurka, H. ^{[1
]}

Traina, F. ^{[1
,2
]}

Jerez, A. ^{[1
]}

O'Keefe, C. ^{[1
]}

Rogers, H. J. ^{[3
]}

Sekeres, M. A. ^{[1
,4
]}

Maciejewski, J. P. ^{[1
,4
]}

Tiu, R. V. ^{[1
,4
]}

机构：

[1] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA

[2] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Natl Inst Blood, Sch Med Sci, Campinas, SP, Brazil

[3] Cleveland Clin, Dept Clin Pathol, Cleveland, OH 44106 USA

[4] Cleveland Clin, Dept Hematol Oncol & Blood Disorders, Taussig Canc Inst, Cleveland, OH 44106 USA

来源：

LEUKEMIA | 2012年 / 26卷 / 03期

关键词：

JAK2 V617F MUTATION; MARKED THROMBOCYTOSIS; MYELODYSPLASTIC SYNDROMES; DNMT3A MUTATIONS; LEUKEMIA; FEATURES; RARS;

D O I：

10.1038/leu.2011.232

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：542 / 545

页数：5

共 16 条

[1] The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS) [J].

Boissinot, Marjorie ;

Garand, Richard ;

Hamidou, Mohamed ;

Hermouet, Sylvie .

BLOOD, 2006, 108 (05) :1781-1782

[2] Ring sideroblasts and sideroblastic anemias [J].

Cazzola, Mario ;

Invernizzi, Rosangela .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (06) :789-792

[3] High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 x 109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable [J].

Gattermann, Norbert ;

Billiet, Johan ;

Kronenwett, Ralf ;

Zipperer, Esther ;

Germing, Ulrich ;

Nollet, Friedel ;

Criel, Arnold ;

Selleslag, Dominik .

BLOOD, 2007, 109 (03) :1334-1335

[4] Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia [J].

Guernsey, Duane L. ;

Jiang, Haiyan ;

Campagna, Dean R. ;

Evans, Susan C. ;

Ferguson, Meghan ;

Kellogg, Mark D. ;

Lachance, Mathieu ;

Matsuoka, Makoto ;

Nightingale, Mathew ;

Rideout, Andrea ;

Saint-Amant, Louis ;

Schmidt, Paul J. ;

Orr, Andrew ;

Bottomley, Sylvia S. ;

Fleming, Mark D. ;

Ludman, Mark ;

Dyack, Sarah ;

Fernandez, Conrad V. ;

Samuels, Mark E. .

NATURE GENETICS, 2009, 41 (06) :651-653

[5]

Hasserjian R P., 2008, WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues, P96

[6] Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1 [J].

Kohlmann, Alexander ;

Grossmann, Vera ;

Klein, Hans-Ulrich ;

Schindela, Sonja ;

Weiss, Tamara ;

Kazak, Beray ;

Dicker, Frank ;

Schnittger, Susanne ;

Dugas, Martin ;

Kern, Wolfgang ;

Haferlach, Claudia ;

Haferlach, Torsten .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (24) :3858-3865

[7] DNMT3A Mutations in Acute Myeloid Leukemia. [J].

Ley, Timothy J. ;

Ding, Li ;

Walter, Matthew J. ;

McLellan, Michael D. ;

Lamprecht, Tamara ;

Larson, David E. ;

Kandoth, Cyriac ;

Payton, Jacqueline E. ;

Baty, Jack ;

Welch, John ;

Harris, Christopher C. ;

Lichti, Cheryl F. ;

Townsend, R. Reid ;

Fulton, Robert S. ;

Dooling, David J. ;

Koboldt, Daniel C. ;

Schmidt, Heather ;

Zhang, Qunyuan ;

Osborne, John R. ;

Lin, Ling ;

O'Laughlin, Michelle ;

McMichael, Joshua F. ;

Delehaunty, Kim D. ;

McGrath, Sean D. ;

Fulton, Lucinda A. ;

Magrini, Vincent J. ;

Vickery, Tammi L. ;

Hundal, Jasreet ;

Cook, Lisa L. ;

Conyers, Joshua J. ;

Swift, Gary W. ;

Reed, Jerry P. ;

Alldredge, Patricia A. ;

Wylie, Todd ;

Walker, Jason ;

Kalicki, Joelle ;

Watson, Mark A. ;

Heath, Sharon ;

Shannon, William D. ;

Varghese, Nobish ;

Nagarajan, Rakesh ;

Westervelt, Peter ;

Tomasson, Michael H. ;

Link, Daniel C. ;

Graubert, Timothy A. ;

DiPersio, John F. ;

Mardis, Elaine R. ;

Wilson, Richard K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (25) :2424-2433

[8] Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML [J].

Link, Daniel C. ;

Schuettpelz, Laura G. ;

Shen, Dong ;

Wang, Jinling ;

Walter, Matthew J. ;

Kulkarni, Shashikant ;

Payton, Jacqueline E. ;

Ivanovich, Jennifer ;

Goodfellow, Paul J. ;

Le Beau, Michelle ;

Koboldt, Daniel C. ;

Dooling, David J. ;

Fulton, Robert S. ;

Bender, R. Hugh F. ;

Fulton, Lucinda L. ;

Delehaunty, Kimberly D. ;

Fronick, Catrina C. ;

Appelbaum, Elizabeth L. ;

Schmidt, Heather ;

Abbott, Rachel ;

O'Laughlin, Michelle ;

Chen, Ken ;

McLellan, Michael D. ;

Varghese, Nobish ;

Nagarajan, Rakesh ;

Heath, Sharon ;

Graubert, Timothy A. ;

Ding, Li ;

Ley, Timothy J. ;

Zambetti, Gerard P. ;

Wilson, Richard K. ;

Mardis, Elaine R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (15) :1568-1576

[9] JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations [J].

Pardanani, A. ;

Vannucchi, A. M. ;

Passamonti, F. ;

Cervantes, F. ;

Barbui, T. ;

Tefferi, A. .

LEUKEMIA, 2011, 25 (02) :218-225

[10] High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis [J].

Renneville, A. ;

Quesnel, B. ;

Charpentier, A. ;

Terriou, L. ;

Crinquette, A. ;

Lai, J-L ;

Cossement, C. ;

Lionne-Huyghe, P. ;

Rose, C. ;

Bauters, F. ;

Preudhomme, C. .

LEUKEMIA, 2006, 20 (11) :2067-2070

← 1 2 →